We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
+$660M
Cap. Flow
+$542M
Cap. Flow %
18.28%
Top 10 Hldgs %
31.64%
Holding
3,611
New
266
Increased
1,484
Reduced
936
Closed
189
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.73%
2 Technology 13.87%
3 Healthcare 8.82%
4 Financials 7.01%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TWST icon
2976
Twist Bioscience
TWST
$8.8B
$905 ﹤0.01%
60
-377
-86% -$8.33K
2021 Q2
7 quarters
HOPE icon
2977
Hope Bancorp
HOPE
$1.72B
$896 ﹤0.01%
91
+1
+1% +$12
2019 Q4
13 quarters
JPC icon
2978
Nuveen Preferred & Income Opportunities Fund
JPC
$2.55B
$895 ﹤0.01%
136
– –
2017 Q1
24 quarters
NNOX icon
2979
Nano X Imaging
NNOX
$35.6M
$883 ﹤0.01%
+153
New +$1.17K
2023 Q1
0 quarters
GSL icon
2980
Global Ship Lease
GSL
$1.49B
$881 ﹤0.01%
47
+21
+81% +$392
2021 Q3
6 quarters
GTN icon
2981
Gray Television
GTN
$451M
$881 ﹤0.01%
101
-68
-40% -$758
2021 Q4
5 quarters
CENX icon
2982
Century Aluminum
CENX
$3.47B
$880 ﹤0.01%
88
+14
+19% +$145
2022 Q3
2 quarters
FATE icon
2983
Fate Therapeutics
FATE
$214M
$878 ﹤0.01%
154
-321
-68% -$1.94K
2020 Q4
9 quarters
TCX icon
2984
Tucows
TCX
$114M
$875 ﹤0.01%
45
-47
-51% -$1.36K
2021 Q1
8 quarters
SFBS icon
2985
ServisFirst Bancshares
SFBS
$4.3B
$874 ﹤0.01%
32
– –
2021 Q2
7 quarters
JBTM icon
2986
JBT Marel
JBTM
$5.41B
$874 ﹤0.01%
8
– –
2021 Q1
8 quarters
LIVN icon
2987
LivaNova
LIVN
$4.27B
$872 ﹤0.01%
20
-13
-39% -$658
2021 Q3
6 quarters
EC icon
2988
Ecopetrol
EC
$36.8B
$866 ﹤0.01%
82
+46
+128% +$499
2017 Q2
23 quarters
CLDX icon
2989
Celldex Therapeutics
CLDX
$2.16B
$864 ﹤0.01%
24
– –
2022 Q2
3 quarters
IDT icon
2990
IDT Corp
IDT
$2B
$852 ﹤0.01%
25
-29
-54% -$893
2021 Q3
6 quarters
HLIO icon
2991
Helios Technologies
HLIO
$2.23B
$850 ﹤0.01%
13
– –
2021 Q3
6 quarters
TWKS icon
2992
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$846 ﹤0.01%
115
-3,192
-97% -$29.6K
2022 Q3
2 quarters
CMPS icon
2993
Compass Pathways
CMPS
$1.49B
$844 ﹤0.01%
85
– –
2021 Q4
5 quarters
LMND icon
2994
Lemonade
LMND
$3.42B
$841 ﹤0.01%
59
-16
-21% -$243
2020 Q4
9 quarters
LUNG icon
2995
Pulmonx
LUNG
$76.4M
$839 ﹤0.01%
75
-75
-50% -$740
2021 Q2
7 quarters
ALIT icon
2996
Alight
ALIT
$237M
$838 ﹤0.01%
5
-1
-17% -$184
2022 Q2
3 quarters
ICUI icon
2997
ICU Medical
ICUI
$4.08B
$825 ﹤0.01%
5
– –
2019 Q3
14 quarters
BBDO icon
2998
Banco Bradesco
BBDO
$39.7B
$819 ﹤0.01%
347
+256
+281% +$606
2022 Q4
1 quarter
LILA icon
2999
Liberty Latin America Class A
LILA
$1.58B
$814 ﹤0.01%
144
– –
2021 Q4
5 quarters
MTRN icon
3000
Materion
MTRN
$5.11B
$812 ﹤0.01%
7
+5
+250% +$501
2022 Q3
2 quarters

Similar funds

Parallel Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Parallel Advisors held 3,611 positions worth $2.97B, up 29% from $2.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $542M of net new capital in Q1 2023, opening 266 new positions and adding to 1,484 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Parallel Advisors's largest Q1 2023 buy was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.
  • Parallel Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q1 2023, an estimated $38.1M increase.
  • Parallel Advisors's biggest Q1 2023 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Parallel Advisors fully exited 1Life Healthcare in Q1 2023, selling an estimated $1.96M.
  • Parallel Advisors's ten largest holdings make up 32% of its $2.97B portfolio in Q1 2023.
  • Parallel Advisors opened 266 new positions and closed 189 in Q1 2023.
  • Parallel Advisors's portfolio value rose 29% quarter-over-quarter to $2.97B.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.